Quantitative assessment of dyskinesias in subhuman primates

Mov Disord. 1999:14 Suppl 1:40-7.

Authors

J M Brotchie¹, S H Fox

Affiliation

¹ Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester, UK.

PMID: 10493402

No abstract available

Publication types

Review

MeSH terms

Adrenergic alpha-Antagonists / therapeutic use
Animals
Anti-Anxiety Agents / therapeutic use
Antiparkinson Agents / adverse effects
Diagnosis, Differential
Dronabinol / analogs & derivatives
Dronabinol / therapeutic use
Dyskinesia, Drug-Induced / diagnosis*
Dyskinesia, Drug-Induced / drug therapy
Dyskinesia, Drug-Induced / etiology
Haplorhini
Idazoxan / therapeutic use
Levodopa / adverse effects
Primates
Severity of Illness Index

Substances

Adrenergic alpha-Antagonists
Anti-Anxiety Agents
Antiparkinson Agents
nabilone
Levodopa
Dronabinol
Idazoxan